“Sticky Blood” – Antiphospholipid Syndrome, POTS, Chronic Fatigue Syndrome and Fibromyalgia – The Dysautonomia Conference #4
This blog is part IV in a series of blogs covering the issues presented at the 2018 Dysautonomia International Conference in Nashville, Tennessee. As if we needed another syndrome. Chronic fatigue syndrome (ME/CFS), postural orthostatic tachycardia syndrome (POTS),...
Are Chronic Fatigue Syndrome, POTS and Fibromyalgia Autoimmune Dysautonomias? IVIG #2
Thinking Outside the Box This is the second of three posts on IVIG treatment and autoimmunity in chronic fatigue syndrome (ME/CFS), POTS and fibromyalgia. It’s time to start thinking outside the traditional ME/CFS/POTS/FM boxes. It’s possible that if you’ve...
An IVIG Chronic Fatigue Syndrome (ME/CFS) / POTS Treatment Success Story: IVIG#1
Suzi’s story is the first in a series of blogs exploring the possibility that the autoimmune findings will open the door for IVIG (Intravenous Immunoglobulin) treatment in chronic fatigue syndrome (ME/CFS), fibromaylgia (FM) and postural orthostatic tachycardia...
The RCCX Hypothesis: Could It Help Explain Chronic Fatigue Syndrome (ME/CFS), Fibromyalgia and other Diseases?
The RCCX hypothesis blog by Remy is the third in a series of blogs by Health Rising which highlight hypotheses produced by health care professionals which attempt to shed a new light on the chronic fatigue syndrome / fibromyalgia spectrum of diseases. What if ME/CFS...
Large NK Cell Study Points to Autoimmunity and Inflammation in Chronic Fatigue Syndrome (ME/CFS)
Studies dating back decades indicate that natural killer cells aren’t up to the job of killing infected cells in ME/CFS. Killing isn’t the only thing these cells do, though, the’re also involved in immune functioning. A large study examining the...Lives Interrupted Latest Story
Bob Graybosch
Lahaina, United States
Former occupation: Resort General Manager
$1,261,443
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
